-
1919P Nintedanib (BIBF1120) after first line therapy in progressive medullary thyroid cancer: A multicenter EORTC prospective randomized double-blind phase II study (NCT01788982)
Katie L. Newbold, Patrick Schoeffski, Baktiar Hasan, Laura D. Locati, Yann Godbert, Christelle de la Fouchardière, +10 more
1citations -
1130P BRAF and MEK inhibition in CDKN2A germline carriers and BRAF mutant melanoma2020 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Francesco Spagnolo, Bruna Dalmasso, Hildur Helgadóttir, Veronica Höiom, Remco van Doorn, Ellen Kapiteijn, +4 more
1citations -
1622MO Clinical benefit with ripretinib as ≥4th line treatment in patients with advanced gastrointestinal stromal tumors (GIST): Update from the phase III INVICTUS study
John Raymond Zalcberg, Michael Charles Heinrich, Suzanne George, Sebastian Bauer, Hans A. J. Gelderblom, Patrick Schöffski, +12 more
1citations -
37P First-line BRAF/MEK-inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: A propensity-matched survival analysis2020 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Jesper van Breeschoten, Michel W.J.M. Wouters, Doranne L. Hilarius, J.B.A.G. Haanen, C.U. Blank, MJB Aarts, +13 more
1citations -
1018P Characterization of liver function tests following tebentafusp in phase III randomized trial comparing tebentafusp with investigator’s choice in first line metastatic uveal melanoma (mUM)
Bartosz Chmielowski, Ellen Kapiteijn, Paolo A. Ascierto, Friedegund Elke Meier, Shaad Essa Abdullah, Patricia Méndez, +1 more
1citations -
9P Long term recurrence risk predictions by CanAssist breast in a sub-cohort of TEAM trial2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
M. Bakre, Arpitha Gunda, Elma Meershoek‐Klein Kranenbarg, B.A. Savitha, C. Prakash, P. Shrivastava, +6 more
1citations -
70P Fluoropyrimidine (FP) dose individualization based on pretreatment uracil levels: Safety and pharmacokinetic (PK) analysis from the Alpe2U study2022 Annals of Oncology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Mirjam de With, Jonathan Emanuel Knikman, A. Baars, G-J.M. Creemers, H.J. Droogendijk, Edward Fiets, +14 more
1citations -
LBA78 Updated efficacy and safety of vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT): One-year follow-up from the MOTION phase III trial2024 Annals of Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments Open access
H. Gelderblom, Vivek A. Bhadri, S. Stacchiotti, Sebastian Bauer, Andrew J. Wagner, Meike van de Sande, +12 more
1citations -
463P A real-world study to evaluate biomarker testing and treatment management in patients with locally advanced unresectable or metastatic G/GEJ adenocarcinoma in France, Germany, Italy, Spain, UK and Canada: Adelphi Real World G/GEJ cancer disease specific programme
Florian Lordick, Emilse Roncancio‐Diaz, Katie Lewis, Annabel Lambert, Georgia N. Thomason, A. Van Oosten, +4 more
1citations -
P-288 Nerve fibers in the tumour microenvironment are co-localized with tertiary lymphoid structures and is associated with better survival in pancreatic cancer patients2020 Annals of Oncology conference-abstract Medicine Pancreatic and Hepatic Oncology Research Open access
Lara Rosaline Heij, Jakob Nikolas Kather, Shivan Sivakumar, Nadine Therese Gaisa, Georg J. Wiltberger, Ulf P. Neumann
0citations -
108P Epigenetic regulation of the putative breast cancer metastasis suppressor gene SCN4B2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Epigenetics and DNA Methylation Open access
Lars Hilgers, Arndt Hartmann, Peter Andreas Fasching, Sophia Villwock, Lorna Moll, Sébastien Roger, +3 more
0citations -
28P EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
J. Leichsenring, Valentina A. Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, +14 more
0citations -
17P Impact of body mass index (BMI) on prognostic and predictive value of stromal tumour-infiltrating lymphocytes (sTILs) in triple-negative breast cancer (TNBC): A pooled analysis of six neoadjuvant trials2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Jenny Furlanetto, Carsten Denkert, Michael Untch, Bruno Valentin Sinn, Bianca Lederer, Andreas Schneeweiß, +9 more
0citations -
21P BACH1 and HIF1α predict response to neoadjuvant nab-paclitaxel (nP) treatment in early breast cancer (BC)2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Valentina A. Vladimirova, Andreas Schneeweiß, Christian Jackisch, Karsten Ernst Weber, Carsten Denkert, Sabine Schmatloch, +13 more
0citations -
218P Differential effects of estrogen exposure on steroid metabolizing CYP enzyme expression in estrogen receptor alpha versus beta positive breast cancer cell lines0citations